Impaired biosynthetic processing of the cys tic fibrosis (CF) transmembrane
conductance regulator (CFTR), a cAMP-regulated chloride channel, constitut
es the most common cause of CE Recently, we have identified a distinct cate
gory of mutation, caused by premature stop codons and frameshift mutations,
which manifests in diminished expression of COOH-terminally truncated CFTR
at the cell surface. Although the biosynthetic processing and plasma membr
ane targeting of truncated CFTRs are preserved. the turnover of the complex
-glycosylated mutant is sixfold faster than its wild-type (wt) counterpart.
Destabilization of the truncated CFTR coincides with its enhanced suscepti
bility to proteasome-dependent degradation from post-Golgi compartments glo
bally, and the plasma membrane specifically, determined by pulse-chase anal
ysis in conjunction with cell surface biotinylation. Proteolytic cleavage o
f the full-length complex-glycosylated wt and degradation intermediates der
ived from both T70 and wt CFTR requires endolysosomal proteases. The enhanc
ed protease sensitivity in vitro and the decreased thermostability of the c
omplex-glycosylated T70 CFTR in vivo suggest that structural destabilizatio
n may account for the increased proteasome susceptibility and the short res
idence time at the cell surface. These in turn are responsible, at least in
part, for the phenotypic manifestation of CE We propose that the proteasom
e-ubiquitin pathway may be involved in the peripheral quality control of ot
her. partially unfolded membrane proteins as well.